These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1114127)

  • 1. [Metabolic and hormonal studies in patients with essential hypertension].
    Januszewicz W; Ciświcka-Sznajderman M; Wocial B; Sznajderman M; Ignatowska-Switalska H; Berent H; Zukowska-Grójec Z
    Pol Tyg Lek; 1975 Feb; 30(7):277-80. PubMed ID: 1114127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma renin activity and urinary excretion of catecholamines and their metabolites in patients with primary arterial hypertension treated with metoprolol].
    Wocial B; Januszewicz W; Sznajderman M; Cybulska I; Brym E; Czerniewska E
    Pol Tyg Lek; 1983 Apr; 38(14):439-42. PubMed ID: 6356082
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between plasma renin activity and urinary catecholamines in individual types of hypertension (author's transl)].
    Horký K; Kopecká J; Gregorová I; Dvoráková J
    Cas Lek Cesk; 1975 Jul; 114(30):920-7. PubMed ID: 1157091
    [No Abstract]   [Full Text] [Related]  

  • 4. Target organ damage and renin-angiotensin-aldosterone system in essential hypertensives with and without metabolic risk factors.
    Fabbian F; Cavallini AR; Caló G; Bagni B; Gilli P; Squerzanti R
    Clin Nephrol; 1997 Feb; 47(2):137-8. PubMed ID: 9049469
    [No Abstract]   [Full Text] [Related]  

  • 5. Endurance exercise in mild hypertension: effects on blood pressure and associated metabolic and quality of life variables.
    Dubbert PM; Martin JE; Cushman WC; Meydrech EF; Carroll RG
    J Hum Hypertens; 1994 Apr; 8(4):265-72. PubMed ID: 8021906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of essential hypertensives based on ion-transport abnormalities: preliminary results.
    De la Sierra A; Coca A; Paré JC; Sobrino J; Sánchez M; Paz MA; Jiménez V; Urbano-Márquez A
    J Hypertens Suppl; 1991 Dec; 9(6):S308-9. PubMed ID: 1668004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholamines and plasma renin activity in renovascular hypertension].
    Januszewicz W; Wocial B
    Kardiol Pol; 1973; 16(4):279-88. PubMed ID: 4756962
    [No Abstract]   [Full Text] [Related]  

  • 9. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome.
    De Pergola G; Giorgino F; Benigno R; Guida P; Giorgino R
    Obesity (Silver Spring); 2008 Nov; 16(11):2405-11. PubMed ID: 18719673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and hormonal metabolic criteria of the activity of coronary arteriosclerosis].
    Vecherskiĭ GA
    Vrach Delo; 1978 Feb; (2):84-8. PubMed ID: 645008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
    Hauner H; Meissner C
    Med Klin (Munich); 1994 Aug; 89(8):403-9. PubMed ID: 7968872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma renin activity in patients with essential hypertension. 1. Results].
    Rinaldi MA; Assennato P; Giardina E; Messina L
    Boll Soc Ital Cardiol; 1976; 21(7):1213-21. PubMed ID: 1031277
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiological studies of essential hypertension. C. Catecholamines].
    Imura O; Sato S; Sawai K; Yamaji I; Miura T; Aoki K; Nishimura M
    Nihon Rinsho; 1984 Feb; 42(2):282-8. PubMed ID: 6371312
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic and humoral variations during the development of essential hypertension].
    Horký K; Jáchymová M; Jindra A; Savlíková J; Peleska J; Umnerová V; Jarolím M
    Vnitr Lek; 1994 May; 40(5):271-7. PubMed ID: 8023466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic derangements in nonmodulating hypertension.
    Gaboury CL; Hollenberg NK; Hopkins PN; Williams R; Williams GH
    Am J Hypertens; 1995 Sep; 8(9):870-5. PubMed ID: 8541001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative hypertension in heart surgery and catecholamine secretion].
    Sarti F; Gallucci V; Giacomini A
    G Clin Med; 1979 Sep; 60(9):748-54. PubMed ID: 400532
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
    Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
    J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.